Cliniphai
Cliniphai builds Athena, an AI-native marketplace platform that uses clinical-tuned LLMs and human-in-the-loop workflows to automate translation and localization for global clinical trials, serving pharma sponsors, CROs, eCOA providers, and language service partners with enterprise-grade compliance.
- Company typePrivate
- Founded2024
- HeadquartersGreat Falls, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Cliniphai does
Cliniphai is a privately held technology company, registered in Wyoming and operationally headquartered in Great Falls, Montana, that builds the Athena platform — an AI-powered marketplace for clinical trial translation and localization. Founded in 2024 by clinical operations, regulatory, and AI engineering veterans (CEO Vladimir Mats, PhD; Chairman Jason Martin; R&D Advisor Yuri Kartashov, PhD), Cliniphai combines an ensemble of clinical-tuned large language models with a proprietary AI 'blender' and human-in-the-loop workflows to produce audit-ready translations for ICFs, COAs, eCOAs, HTA dossiers, and patient-facing materials. The platform supports ISO 27001, ISO 17100, ISPOR, and GDPR alignment, AES-256/TLS 1.3 encryption, visual workflow builders (Gantt/Kanban), real-time collaboration, and API/webhook integration with EDC and eCOA systems, with deployment options including dedicated VPC and on-premises.
Cliniphai sells to four primary enterprise segments: pharma and biotech sponsors, contract research organizations (CROs), electronic Clinical Outcome Assessment (eCOA) providers, and localization providers / language service partners. Revenue mechanics combine subscription-based enterprise licensing (multi-year contracts with dedicated VPC or on-prem deployment), usage-based API integration fees, and a marketplace model connecting certified language freelancers and reviewers with sponsors and CROs. Pricing is quote-based and not publicly disclosed; go-to-market combines direct enterprise field sales (Calendly-driven demos and guided onboarding), API-first distribution for embedded integrations, and event-driven demand generation through major industry conferences such as ISPOR Europe 2025 and BIO 2025.
The company has scaled rapidly since launching Athena in March 2025: it unveiled a marketplace model at BIO 2025 (June 2025), added senior leadership from Medidata (Donna Wallace as CCO, Michael Arbitman as Chief of Staff), formed strategic partnerships with Adherence (March 2025), Gibson Research Consultancy (September 2025), and Nested Knowledge (November 2025), and won a Gold Stevie Award in April 2026. Engineering and R&D operations include a 17-person development team in Kyiv, Ukraine, supporting a globally distributed workforce fluent in 10+ languages. Distribution is anchored in the United States with stated global reach through partnership channels.
Cliniphai firmographics
Firmographics- Name
- Cliniphai
- Legal name
- Cliniphai LLC
- Website
- https://cliniphai.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cliniphai builds Athena, an AI-native marketplace platform that uses clinical-tuned LLMs and human-in-the-loop workflows to automate translation and localization for global clinical trials, serving pharma sponsors, CROs, eCOA providers, and language service partners with enterprise-grade compliance.
- Ownership category
- akta.pro rank
Cliniphai industry classification
Industry- Product category
- Clinical Trial Translation Software
- NAICS
- Software Publishers (513210), Custom Computer Programming Services (541511), Translation and Interpretation Services (541930)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
- akta.pro primary industry
- Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)
Keywords
Where Cliniphai is headquartered
LocationHeadquarters
- HQ city
- Great Falls
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Cliniphai business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Athena Platform Licensing: AI-powered clinical translation and localization platform offered as enterprise licensing with dedicated VPC deployment or on-premises options for data residency requirements.
- Marketplace Services: Marketplace model connecting sponsors, CROs, eCOA providers, and language experts with built-in workflow management, version tracking, and compliance controls.
- API Integration Services: Real-time API integration, webhooks, and REST endpoints for syncing jobs, statuses, terminology, and system events with customer environments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise platform with dedicated VPC deployment and 12-month SLA |
| Subscription | Multi-year contract | On-premises deployment option for maximum security |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels4 records
Cliniphai product offering
Product offeringCore offering
Cliniphai develops and sells the Athena platform, an AI-powered marketplace for clinical trial translation and localization used by life sciences companies. The platform combines multiple clinical-tuned large language models with human-in-the-loop validation to deliver multilingual clinical content (informed consent forms, patient-facing materials, regulatory dossiers, COA/eCOA instruments) with ISPOR, ISO 27001, and ISO 17100 compliance. It connects pharmaceutical sponsors, CROs, eCOA providers, and certified language freelancers through API-driven integration with EDC systems and dedicated VPC or on-premises deployments.
Product overview
Cliniphai is an AI Agent and Framework platform purpose-built for life sciences, featuring its flagship product Athena as a unified AI-native marketplace for clinical translation and localization. Athena combines multiple clinical-tuned large language models (LLMs) with human-in-the-loop validation to deliver regulatory-compliant translations at scale. The platform connects sponsors, CROs, eCOA providers, and language professionals through a centralized ecosystem with real-time collaboration tools, visual workflow builders, version tracking, QA checkpoints, and enterprise-grade security infrastructure including private VPC deployment options.
Differentiator
Problem solved
Functional benefit
Brands
- Athena: AI-native marketplace platform for clinical translation and localization that combines AI-powered workflows with built-in compliance and operational transparency, supporting sponsors, eCOA providers, and language experts for secure, scalable, and collaborative execution across global studies.
Products and services
- Athena Athena is an AI-native marketplace platform for clinical translation and localization that combines multiple clinical-tuned large language models (LLMs) with human-in-the-loop validation to deliver regulatory-compliant translations at scale. It connects pharmaceutical sponsors, CROs, eCOA providers, translation freelancers, and reviewers in a centralized, audit-ready environment with built-in ISPOR-compliant workflows, real-time collaboration tools, visual workflow builders, version tracking, QA checkpoints, and enterprise-grade security including dedicated VPC deployment and 12-month SLA.
Quantifiable outcome
- 3x faster localization compared to traditional methods
- +3 more outcomes
Companies that use Cliniphai
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Cliniphai technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability7 records
Feature6 records
Cliniphai partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- Nested KnowledgecoreStrategic partnership at ISPOR Europe 2025 combining Cliniphai's Athena localization platform with Nested Knowledge's evidence synthesis technology. The collaboration delivers AI-enabled human-in-the-loop translations for HTA dossier components, rapid adaptation of dossiers for global health authorities, and improved accuracy through built-in regulatory alignment.
- Gibson Research Consultancy (GRC)corePartnership with global leader in health communication and linguistic validation for COA and eCOA. GRC performs full suite of linguistic validation services directly through Cliniphai's Athena platform. GRC has completed 11,000+ COA and eCOA validation projects across 250+ languages in 190+ countries. Platform enables project visibility, version tracking, ISPOR-compliant workflows, and integrated QA monitoring.
- AdherenceflagshipPartnership with digital health startup specializing in medication adherence predictive analytics. Collaboration aims to expand access to high-quality adherence data, transforming clinical translation and localization in global healthcare. Includes 24-hour global adherence initiative with ATLAS platform collecting 1,000+ real-time adherence assessments. Landmark project to localize MMAS condition-specific instruments into 5 additional languages (Russian, Arabic, Chinese, Japanese, French) with potential 3x speed increase and 2-3x cost reduction.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Cliniphai competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key highlights7 records
Customer concentration
Cliniphai compliance and trust
Trust signalCompliance5 records
Cliniphai financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cliniphai leadership team
Management profileNumber of profiles
Profiles7 records
Cliniphai funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cliniphai M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cliniphai
What does Cliniphai do?
Cliniphai develops and sells the Athena platform, an AI-powered marketplace for clinical trial translation and localization used by life sciences companies. The platform combines multiple clinical-tuned large language models with human-in-the-loop validation to deliver multilingual clinical content (informed consent forms, patient-facing materials, regulatory dossiers, COA/eCOA instruments) with ISPOR, ISO 27001, and ISO 17100 compliance. It connects pharmaceutical sponsors, CROs, eCOA providers, and certified language freelancers through API-driven integration with EDC systems and dedicated VPC or on-premises deployments.
Is Cliniphai a public or private company?
Cliniphai is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cliniphai founded?
Cliniphai was founded in 2024. It employs 11 to 50 people.
Where is Cliniphai based?
Cliniphai is headquartered in Great Falls, United States, in the North America region.
How does Cliniphai make money?
Three revenue lines are on record. Athena Platform Licensing is the primary driver. The others are marketplace Services and API Integration Services.
Does Cliniphai have an API?
Yes. Athena offers real-time API integration with REST endpoints and webhooks, enabling sync of jobs, statuses, terminology, and system events across eCOA platforms, EDC systems, and internal sponsor environments.
What industry is Cliniphai in?
Cliniphai's product category is Clinical Trial Translation Software. Its primary akta.pro industry code is HLAGAAAG, Medical Writing & Regulatory Submission Support CROs, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 513210 and its SIC code is 7372.